Protein biomarker signature for risk classification of hormone receptor positive breast cancer identified by reverse phase protein array based tumor profiling

被引：0
|
作者：
Sonntag, J. [1 ]
Bender, C. [1 ]
Aulmann, S. [2 ]
Von der Heyde, S. [3 ]
Burwinkel, B. [4 ]
Wiemann, S. [1 ]
Beissbarth, T. [3 ]
Sinn, H. P. [2 ]
Schneeweiss, A. [5 ]
Korf, U. [1 ]
机构：
[1] German Canc Res Ctr, Heidelberg, Germany
[2] Heidelberg Univ, Dept Pathol, Heidelberg, Germany
[3] Univ Med Ctr Gottingen, Dept Med Stat, Gottingen, Germany
[4] Heidelberg Univ, Dept Gynecol & Obstet, Heidelberg, Germany
[5] Heidelberg Univ, Natl Ctr Tumor Dis, Heidelberg, Germany
来源：
EUROPEAN JOURNAL OF CANCER | 2013年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1010
引用
收藏
页码：S212 / S212
页数：1
相关论文
共 50 条
  • [1] Reverse phase protein array in breast cancer classification.
    Hennessy, BT
    Lu, Y
    Tibes, R
    Gozalez-Angulo, AM
    Hortobagyi, GN
    Valero, V
    Mills, GB
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S114 - S115
  • [2] The Merits of Reverse Phase Protein Array for Molecular Classification of Breast Cancer
    Negm, O. H.
    Muftah, A. A.
    Aleskandarany, M. A.
    Hamed, M. R.
    Ahmad, D. A. J.
    Nolan, C. C.
    Rodriguez, M. D.
    Tighe, P. J.
    Ellis, I. O.
    Rakha, E. A.
    Green, A. R.
    JOURNAL OF PATHOLOGY, 2016, 240 : 15 - 15
  • [3] Breast Cancer Proteomic Profiling Using Reverse Phase Protein Array (RPPA)
    Negm, O. H.
    Alshareeda, A. T.
    Aleskandarany, M. A.
    Green, A. G.
    Ellis, I. O.
    Rakha, E. A.
    Tighe, P. J.
    JOURNAL OF PATHOLOGY, 2013, 231 : 13 - 13
  • [4] Clinical utility of reverse phase protein array for molecular classification of breast cancer
    Negm, Ola H.
    Muftah, Abir A.
    Aleskandarany, Mohammed A.
    Hamed, Mohamed R.
    Ahmad, Dena A. J.
    Nolan, Christopher C.
    Diez-Rodriguez, Maria
    Tighe, Patrick J.
    Ellis, Ian O.
    Rakha, Emad A.
    Green, Andrew R.
    BREAST CANCER RESEARCH AND TREATMENT, 2016, 155 (01) : 25 - 35
  • [5] Clinical utility of reverse phase protein array for molecular classification of breast cancer
    Ola H. Negm
    Abir A. Muftah
    Mohammed A. Aleskandarany
    Mohamed R. Hamed
    Dena A. J. Ahmad
    Christopher C. Nolan
    Maria Diez-Rodriguez
    Patrick J. Tighe
    Ian O. Ellis
    Emad A. Rakha
    Andrew R. Green
    Breast Cancer Research and Treatment, 2016, 155 : 25 - 35
  • [6] Identification of a Biomarker Signature to Predict the Need for Chemotherapy in Patients With Hormone Receptor Positive Breast Cancer
    Korf, U.
    Sonntag, J.
    Bender, C.
    Wiemann, S.
    Aulmann, S.
    Sinn, P.
    Burwinkel, B.
    Schneeweiss, A.
    Beissbarth, T.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : S203 - S204
  • [7] Reverse phase protein microarrays quantify and validate the bioenergetic signature as biomarker in colorectal cancer
    Aldea, M.
    Clofent, J.
    Nunez de Arenas, C.
    Chamorro, M.
    Velasco, M.
    Berrendero, J. R.
    Navarro, C.
    Cuezva, J. M.
    CANCER LETTERS, 2011, 311 (02) : 210 - 218
  • [8] Novel biomarkers of nasopharyngeal carcinoma metastasis risk identified by reverse phase protein array based tumor profiling with consideration of plasma Epstein-Barr virus DNA load
    Xu, Tao
    Su, Bojin
    Huang, Peiyu
    Wei, Weihong
    Deng, Yanming
    Sehgal, Vasudha
    Wang, Donghui
    Jiang, Jun
    Zhang, Guoyi
    Li, Anfei
    Yang, Huiling
    Claret, Francois X.
    PROTEOMICS CLINICAL APPLICATIONS, 2017, 11 (5-6)
  • [9] Signaling pathway profiling by reverse-phase protein array for personalized cancer medicine
    Masuda, Mari
    Yamada, Tesshi
    BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2015, 1854 (06): : 651 - 657
  • [10] Reverse-Phase Protein Array Analysis to Identify Biomarker Proteins in Human Pancreatic Cancer
    Yu-Jing Huang
    Marsha L. Frazier
    Nianxiang Zhang
    Qian Liu
    Chongjuan Wei
    Digestive Diseases and Sciences, 2014, 59 : 968 - 975
12345